Serum Institute to invest an additional $150 million in Biocon Biologics

  • Serum Institute Life Sciences will double its investment in Biocon Biologics from $150 million to $300 million.
  • This is an additional investment from the one announced in 2021.


Sign Up for nextbigwhat newsletter

The smartest newsletter, partly written by AI.

Download, the short news app for busy professionals